Innodata Inc vs Eli Lilly And Co — how do they compare? Innodata Inc trades at $62.81 (market cap $2.03B), while Eli Lilly And Co trades at $1,159.75 (market cap $1.02T). The key difference: Eli Lilly And Co is far larger — about 502.5× Innodata Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Innodata Inc pays none. Which is the better fit depends on your goals.
| INOD | LLY | |
|---|---|---|
Market Cap | $2.03B | $1.02T |
Sector | Technology | Health |
52-Week High | $121.50 | $1.24K |
52-Week Low | $34.45 | $625.65 |
Enterprise Value | $1.91B | $1.06T |
Dividend Yield | — | 0.6% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.
Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.
Trailing returns across standard periods
Latest headlines on both assets
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →